LexDanaLexDanabeta
Inventor

Mark Matteucci

Inventor
Burlingame, CA, US

Overview

68→
Patents
1984–2020
Patent span
Chemistry
Primary field (CPC C)

Patents· 68 as inventor

Public. Assignee & technology derived from the patent record. Each patent links to its LexDana page.

C07Hprimary
C07HSugars23%
C12QMeasuring or testing processes involving enzymes, nucleic acids or microorganisms12%
A61KPreparations for medical, dental or toiletry purposes11%
A61PSpecific therapeutic activity of chemical compounds or medicinal preparations9%
Y02PClimate change mitigation technologies in the production or processing of goods9%
C07FAcyclic, carbocyclic or heterocyclic compounds containing elements other than carbon, hydrogen, halogen, oxygen, nitrogen, sulfur, selenium or tellurium8%
C07DHeterocyclic compounds7%
C12NMicroorganisms or enzymes6%
B01JChemical or physical processes, e.g. catalysis or colloid chemistry2%
C07CAcyclic or carbocyclic compounds2%
PatentTitleYear
10,829,437Nitrobenzyl derivatives of anti-cancer agents202010,766,914DNA alkylating agents202010,668,047Aziridine containing DNA alkylating agents202010,654,876TH-302 solid forms and methods related thereto202010,409,869(R)- and (S)-1-(3-(3-N,N-dimethylaminocarbonyl)phenoxyl-4-nitrophenyl)-1-ethyl-N,N'-bis (ethylene)phosphoramidate, compositions and methods for their use and preparation201910,364,261DNA alkylating agents201910,131,683TH-302 solid forms and methods related thereto20189,226,932'Phosphoramidate alkylator prodrugs'20168,946,275'Treatment of cancer using hypoxia activated prodrugs'20158,664,204'Phosphoramidate alkylator prodrugs'20148,653,248'2-aminopyridine and 2-pyridone C-nucleosides'20148,575,188'Camptothecin derivatives'20138,552,048'Phosphoramidate alkylator prodrugs for the treatment of cancer'20138,507,464'Phosphoramidate alkylator prodrugs'20138,309,554'Hypoxia activated drugs of nitrogen mustard alkylators'20128,299,088'Compositions and methods for treating cancer'20128,003,625'Phosphoramidate alkylator prodrugs'20117,550,496'Compositions and methods for treating cancer'20097,511,125'Pyrimidine derivatives for labeled binding partners'2009RE039324'Pyrimidine derivatives and oligonucleotides containing same'20067,001,888'Compositions and methods for treating cancer'20066,989,140'Methods for cancer imaging'20066,967,079'Pyrimidine derivatives for labeled binding partners'20056,962,783'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'20056,951,931'Pyrimidine derivatives for labeled binding partners'20056,911,540'2′ Modified oligonucleotides'20056,875,593'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'20056,800,743'Pyrimidine derivatives for labeled binding partners'20046,683,166'Modified internucleoside linkages (ii)'20046,617,437'Pyrimidine derivatives for labeled binding partners'20036,495,672'Oligonucleotides including 2-aminopyridine and 2-pyridone C-nucleoside units'20026,476,205'2 Modified oligonucleotides'20026,447,998'2-Aminopyridine and 2-pyridone C-nucleosides, oligonucleotides comprising, and tests using the same oligonucleotides'20026,414,127'Pyrimidine derivatives for labeled binding partners'20026,410,702'Modified internucleoside linkages (II)'20026,028,183'Pyrimidine derivatives and oligonucleotides containing same'20006,007,992'Pyrimidine derivatives for labeled binding partners'19996,005,096'Pyrimidine derivatives'19995,830,653'Methods of using oligomers containing modified pyrimidines'19985,817,781'Modified internucleoside linkages (II)'19985,792,847'2\' Modified Oligonucleotides'19985,792,608'Nuclease stable and binding competent oligomers and methods for their use'19985,777,153'Cationic lipids'19985,763,588'Pyrimidine derivatives for labeled binding partners'19985,705,693'Cationic lipids'19985,672,697'Nucleoside 5\'-methylene phosphonates'19975,646,269'Method for oligonucleotide analog synthesis'19975,645,985'Enhanced triple-helix and double-helix formation with oligomers containing modified pyrimidines'19975,596,086'Modified internucleoside linkages having one nitrogen and two carbon atoms'19975,594,121'Enhanced triple-helix and double-helix formation with oligomers containing modified purines'19975,548,076'Method of making oligonucleotides, oligonucleoside thiophosphates and oligonucleoside phosphotriesters using H-phosphonate intermediates'19965,502,177'Pyrimidine derivatives for labeled binding partners'19965,495,009'Oligonucleotide analogs containing thioformacetal linkages'19965,466,786'2\'modified nucleoside and nucleotide compounds'19955,434,257'Binding compentent oligomers containing unsaturated 3\',5\' and 2\',5\' linkages'19955,414,077'Non-nucleoside linkers for convenient attachment of labels to oligonucleotides using standard synthetic methods'19955,264,566'Method for in vitro oligonucleotide synthesis using H-phosphonates'19935,264,564'Oligonucleotide analogs with novel linkages'19935,264,562'Oligonucleotide analogs with novel linkages'19935,214,136'Anthraquinone-derivatives oligonucleotides'19935,175,273'Nucleic acid intercalating agents'19925,153,319'Process for preparing polynucleotides'19925,132,418'Process for preparing polynucleotides'19925,010,003'Use of yeast homologous signals to secrete heterologous proteins'19914,959,463'Intermediates'19904,923,808'Method for identifying mutants secreting high levels of heterologous proteins'19904,500,707'Nucleosides useful in the preparation of polynucleotides'19854,458,066'Process for preparing polynucleotides'1984

Career & activity timeline

Assembled from patent assignee/location history and declaration credentials.

1984–1992Based in Boulder, CO, US· patent location history
1990–1996Patents assigned to GENENTECH INC (6)· patent assignee history
1990–2013Based in Redwood City, CA, US· patent location history
1992–2005Based in Burlingame, CA, US· patent location history
1993–2000Patents assigned to GILEAD SCIENCES INC (20)· patent assignee history
1999–2020Based in Portola Valley, CA, US· patent location history
2002–2014Patents assigned to ISIS PHARMACEUTICALS INC (16)· patent assignee history
2006–2016Patents assigned to THRESHOLD PHARMACEUTICALS INC (11)· patent assignee history
2012–2015Patents assigned to MATTEUCCI MARK (6)· patent assignee history
2019–2020Based in South San Francisco, CA, US· patent location history

Inventor activity

Assignee and location history derived from the patent record.

Assignees
AssigneePatentsSpan
GILEAD SCIENCES INC201993–2000
ISIS PHARMACEUTICALS INC162002–2014
THRESHOLD PHARMACEUTICALS INC112006–2016
GENENTECH INC61990–1996
MATTEUCCI MARKself62012–2015
Locations
LocationPatentsSpan
Burlingame, California, US281992–2005
Portola Valley, California, US221999–2020
South San Francisco, California, US42019–2020
Redwood City, California, US41990–2013
Boulder, CO, US31984–1992